Jyothy Labs has cash to buy growth. Why it isn't rushing
MUMBAI, Oct. 2 -- Jyothy Labs has Rs.997 crore in cash, no debt, and a portfolio under pressure after German consumer-goods company Henkel AG ended its 15-year licensing arrangement for Pril and Fa in May. Yet the consumer-goods maker is not rushing to acquire brands to fill the gap.
Instead, managing director M.R. Jyothy is betting on new products, stronger existing brands and a larger personal-care business. The strategy is unfolding as crude-linked input costs squeeze margins and competition intensifies across some of the company's biggest categories.
"I don't want to rush into something that could create a problem for us for years to come," Jyothy said.
That approach contrasts with the broader consumer-goods sector, where peers hav...
Click here to read full article from source
इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया
हमे संपर्क करें.